Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Tax Provisions (2022 - 2025)

Historic Tax Provisions for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $5000.0.

  • TriSalus Life Sciences' Tax Provisions rose 26666.67% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6000.0, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $6000.0 for FY2024, which is 3333.33% down from last year.
  • As of Q3 2025, TriSalus Life Sciences' Tax Provisions stood at $5000.0, which was up 26666.67% from -$3000.0 recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Tax Provisions ranged from a high of $28202.0 in Q2 2022 and a low of -$5000.0 during Q1 2023
  • Its 4-year average for Tax Provisions is $4683.5, with a median of $4000.0 in 2024.
  • Its Tax Provisions has fluctuated over the past 5 years, first crashed by 20000.0% in 2024, then surged by 26666.67% in 2025.
  • TriSalus Life Sciences' Tax Provisions (Quarter) stood at $6000.0 in 2022, then plummeted by 83.33% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024, then skyrocketed by 600.0% to $5000.0 in 2025.
  • Its last three reported values are $5000.0 in Q3 2025, -$3000.0 for Q2 2025, and $5000.0 during Q1 2025.